Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Muhammad Wasif Saif. (2014) Advanced stage pancreatic cancer: novel therapeutic options. Expert Review of Clinical Pharmacology 7:4, pages 487-498.
Read now
Read now
Jia Li, Nikolai Podoltsev & Muhammad W Saif. (2009) Management of advanced pancreatic cancer. Expert Review of Clinical Pharmacology 2:5, pages 527-541.
Read now
Read now
M Wasif Saif, Ewan Tytler, Frederick Lansigan, David M Brown & Alan J Husband. (2009) Flavonoids, phenoxodiol, and a novel agent, triphendiol, for the treatment of pancreaticobiliary cancers. Expert Opinion on Investigational Drugs 18:4, pages 469-479.
Read now
Read now
Articles from other publishers (5)
Zhi-Xin Wang, Jiazhi Sun, Caitlin E. Howell, Qing-Yu Zhou, Zhi-Xu He, Tianxin Yang, Helen Chew, Wei Duan, Zhi-Wei Zhou, Jagat R. Kanwar & Shu-Feng Zhou. (2014) Prediction of the likelihood of drug interactions with kinase inhibitors based on in vitro and computational studies. Fundamental & Clinical Pharmacology 28:5, pages 551-582.
Crossref
Crossref
Rajeev S. Samant & Lalita A. Shevde. (2011) Recent Advances in Anti-Angiogenic Therapy of Cancer. Oncotarget 2:3, pages 122-134.
Crossref
Crossref
Soumya Jaganathan, Peibin Yue & James Turkson. (2010) Enhanced Sensitivity of Pancreatic Cancer Cells to Concurrent Inhibition of Aberrant Signal Transducer and Activator of Transcription 3 and Epidermal Growth Factor Receptor or Src. Journal of Pharmacology and Experimental Therapeutics 333:2, pages 373-381.
Crossref
Crossref
Jason G. Kettle & Richard A. Ward. (2010) Toward the Comprehensive Systematic Enumeration and Synthesis of Novel Kinase Inhibitors Based on a 4-Anilinoquinazoline Binding Mode. Journal of Chemical Information and Modeling 50:4, pages 525-533.
Crossref
Crossref
Shu-Feng Zhou. 2010. Supportive Cancer Care with Chinese Medicine. Supportive Cancer Care with Chinese Medicine
293
340
.